Palatin Technologies, Inc. Share Price Nyse
Equities
PTN
US6960773041
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 4.13M 343M | Sales 2025 * | 5.25M 436M | Capitalization | 29.05M 2.41B |
---|---|---|---|---|---|
Net income 2024 * | -34M -2.83B | Net income 2025 * | -30M -2.49B | EV / Sales 2024 * | 7.04 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.53 x |
P/E ratio 2024 * |
-0.78
x | P/E ratio 2025 * |
-1.53
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.84% |
Latest transcript on Palatin Technologies, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Carl Spana
FOU | Founder | 61 | 21/86/21 |
Stephen Wills
DFI | Director of Finance/CFO | 67 | 01/97/01 |
John Dodd
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Prendergast
FOU | Founder | 70 | 21/86/21 |
Carl Spana
FOU | Founder | 61 | 21/86/21 |
Robert deVeer
BRD | Director/Board Member | 78 | 01/98/01 |
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.15% | 21.96B | |
-9.23% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- PTN Stock
- PTN Stock